WIH Researchers Examine Role of Hormone HE4 in Patient Responses to Ovarian Cancer Treatment

Researchers at Women & Infants’ Hospital of Rhode Island recently published the results of an investigation into the role of hormone HE4 in patient responses to ovarian cancer treatment.

Source: Libby's H*O*P*E* - September 19, 2014 Category: Cancer & Oncology Authors: Paul Cacciatore Tags: Anti-Estrogen Therapy Discoveries Preclinical Testing fulvestrant hormone HE4 ivermectin ovarian cancer Richard G. Moore MD tamoxifen Women & Infants Hospital Source Type: blogs